Thats why we combed Reddit to find out what people are currently talking about in obesity and GLP-1 communities and asked the following medical experts to respond to readers most pressing questions: Kia Mitchell, MD Double board-certified family and obesity medicine physician and founder of the International Womens Obesity Network Marsha Novick, MD, FAAFP Spokesperson for The Obesity Society and board member of the American Board of Obesity Medicine Richele Corrado, DO, MPH Spokesperson for The Obesity Society and medical director, internist, and obesity medicine physician at Revolution Medicine, Health & Fitness Sherrie Singh-Bryan, PharmD, CDCES Clinical pharmacist and certified diabetic care and education specialist at Winn Army Community Hospital in Fort Stewart, Georgia Editors note: These interviews have been edited for length and clarity
Tolerability tends to mirror the other appetite agents
Researchers selecting compounds must now navigate a complex hierarchy of affinity, ranging from the highly specific Semaglutide to the dual-agonist Tirzepatide, and now the experimental frontier of triple-agonists like Retatrutide
Does retatrutide have benefits beyond appetite suppression
Many patients qualify with a BMI of 27 or higher if they also have one or more weight-related medical conditions
How Long Tirzepatide Stays in Your System After One Dose vs Long-Term Use The elimination timeline is similar whether you take one dose or use tirzepatide long term
.webp)
